Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesbuvir + Peg-Intron + Rebetol in HCV Genotype 1
NCT00367887Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of nesbuvir in hepatitis C (HCV), sponsored by Pfizer. Started Oct 2006; status: completed.
02
Drugs
nesbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00367887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367887.